跳至主要内容
临床试验/EUCTR2012-002228-34-ES
EUCTR2012-002228-34-ES进行中(未招募)不适用

Growth hormone (GH) angiogenic effect clinical trial on patients with lower limb critical ischemia. GHAS Study - GHAS

Diego Caicedo Valdés0 个研究点开始时间: 2012年9月14日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with lower limbs critical ischemia by mean: trophic lesions and/or rest pain and/or night pain of ischemic origin and ankle-brachial index (ABI) equal or lower than 0.4
  • Failed previous attempts of revascularization through main methods: surgical and/or endovascular therapies.
  • High risk of loss limb
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 20

排除标准

  • Fertile women
  • Aged under 18
  • Legally incapable
  • Onchologic patients

研究者

发起方
Diego Caicedo Valdés

相似试验